Harwars has passed the supervision and inspection of GCP expansion of veterinary drugs

On May 6th, the Animal Husbandry and Veterinary Bureau of the Ministry of Agriculture and Rural Affairs issued a notice on the publication of the supervision and inspection results of non clinical research quality management standards for veterinary drugs and clinical trial quality management standards for veterinary drugs (the 31st batch). Harwars is a unit that meets the requirements of clinical trial quality management standards for veterinary drugs.

After this expansion supervision and inspection, Harwars's GCP service projects cover the safety and effectiveness testing evaluation of poultry (chickens/ducks/geese/pigeons), pigs, and pets (dogs/cats) of biological products. In the later stage, on the basis of GCP biological product services, we will gradually carry out safety and effectiveness tests for animal disinfectants, pharmacokinetic tests for animal Chinese chemical drugs, and GLP testing projects for Chinese chemical drugs such as GCP and acute toxicity tests and subchronic toxicity tests.

Harwars is mainly engaged in CRO and CDMO services, research and development of biological products and new veterinary drugs, as well as food, agricultural products, health products, environmental testing of production areas, safety analysis and functional evaluation, animal disease and cosmetic testing, and other businesses. We have 12000 square meters of animal experimental facilities and have obtained qualifications such as laboratory animal use license, CMA, CNAS, etc.

At present, we have long-term cooperative clients such as Zoetis, Shihua, Ulan Biology, Dingzhi Biology, Binzhou Huahong, Binzhou Lvdu, and other veterinary drug research and production enterprises. We also have research institutes in universities such as Shanghai Veterinary Research Institute, Chongqing Academy of Animal Sciences, Zhejiang Veterinary Research Institute, and Qingdao Agricultural University.